Murielle M. Véniant
Amgen (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Pancreatic function and diabetes, Fibroblast Growth Factor Research, Metabolism, Diabetes, and Cancer, Hormonal Regulation and Hypertension
Most-Cited Works
- → Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice(2008)1,133 cited
- → Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice(1999)424 cited
- → Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effects(2009)334 cited
- → Knockout of the abetalipoproteinemia gene in mice: Reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes(1998)259 cited
- → A mouse model of human familial hypercholesterolemia: Markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet(1998)231 cited
- → Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys(2017)227 cited